{"disease":{"id":"telitacicept","name":"telitacicept"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07053137","title":"A Comparative Study of the Efficacy and Safety of Telitacicept and Belimumab in the Treatment of Systemic Lupus Erythematosus Involving Multiple Units, Based on Previous Data.","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":180,"lead_sponsor_name":"Yipeng Liu","has_results":false},{"nct_id":"NCT05588830","title":"The Efficacy and Safety of Telitacicept and Belimumab in Active Lupus Nephritis in the Real World: a Prospective Cohort Study","phase":"","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","has_results":false},{"nct_id":"NCT06137053","title":"Effect of Telitacicept on Transitional Regulatory B Cells in Patients With Systemic Lupus Erythematosus","phase":"","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Yanfeng Hou","has_results":false},{"nct_id":"NCT07491016","title":"Efficacy and Safety of Telitacicept Combined With Baricitinib for Refractory Rheumatoid Arthritis","phase":"","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Zhejiang Provincial People's Hospital","has_results":false},{"nct_id":"NCT06979271","title":"Efficacy and Safety of Telitacicept Combined With Tofacitinib for Refractory Rheumatoid Arthritis","phase":"","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Zhejiang Provincial People's Hospital","has_results":false},{"nct_id":"NCT06125405","title":"Study of the Telitacicept in Pediatric Patients With Frequently Relapsing or Steroid Dependent Nephrotic Syndrome","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"The Children's Hospital of Zhejiang University School of Medicine","has_results":false}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}